FIN-FSA fines Savcor Technologies, and BBS-Bioactive Bone Substitutes

The failures included omissions to notify managers’ transactions on time, and not informing individuals about their regulatory obligations.

Finanssivalvonta, the Finnish Financial Supervisory Authority (FIN-FSA), has issued two fines totalling €130,000 ($140,300) on two separate companies relating to failures connected with the EU’s Market Abuse Regulation.

The first fenalty of a combined €100,000 ($107,930) was issued to Savcor Technologies Oy for failing to notify managers’ transactions, and for stating an incorrect date

Free Trial

Register for free to keep reading.

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free Already a member? Sign in